DE60239281D1 - Verfahren zur diagnose eines hirninfarkts - Google Patents

Verfahren zur diagnose eines hirninfarkts

Info

Publication number
DE60239281D1
DE60239281D1 DE60239281T DE60239281T DE60239281D1 DE 60239281 D1 DE60239281 D1 DE 60239281D1 DE 60239281 T DE60239281 T DE 60239281T DE 60239281 T DE60239281 T DE 60239281T DE 60239281 D1 DE60239281 D1 DE 60239281D1
Authority
DE
Germany
Prior art keywords
glycoprotein
concentration
beta
infarc
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60239281T
Other languages
German (de)
English (en)
Inventor
Takao Koike
Tatsuya Atsumi
Hisao Kato
Hideyuki Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LSI Medience Corp
Original Assignee
Mitsubishi Chemical Medience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Medience Corp filed Critical Mitsubishi Chemical Medience Corp
Application granted granted Critical
Publication of DE60239281D1 publication Critical patent/DE60239281D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DE60239281T 2001-10-11 2002-10-11 Verfahren zur diagnose eines hirninfarkts Expired - Lifetime DE60239281D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001314357A JP4070443B2 (ja) 2001-10-11 2001-10-11 脳梗塞を検出する方法
PCT/JP2002/010610 WO2003034066A1 (en) 2001-10-11 2002-10-11 Method of diagnosing cerebral infarction

Publications (1)

Publication Number Publication Date
DE60239281D1 true DE60239281D1 (de) 2011-04-07

Family

ID=19132685

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60239281T Expired - Lifetime DE60239281D1 (de) 2001-10-11 2002-10-11 Verfahren zur diagnose eines hirninfarkts

Country Status (6)

Country Link
US (2) US20040248200A1 (enExample)
EP (1) EP1443326B1 (enExample)
JP (1) JP4070443B2 (enExample)
AT (1) ATE499608T1 (enExample)
DE (1) DE60239281D1 (enExample)
WO (1) WO2003034066A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1853631T3 (en) * 2005-01-24 2016-03-29 Univ Texas Fc-FUSION CONSTRUCTIONS BINDING TO PHOSPHATIDYLSERINE AND THERAPEUTIC APPLICATION THEREOF
JP6312302B2 (ja) * 2014-01-06 2018-04-18 公益財団法人ヒューマンサイエンス振興財団 脳梗塞の診断マーカー
CN117568445B (zh) * 2024-01-18 2024-04-09 西南交通大学 一种tat、pic复合质控品的制备方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2172247A1 (en) * 1993-09-29 1995-04-06 Eiji Matsuura Method of assaying oxidized lipoprotein and application thereof
JP2000028607A (ja) * 1998-07-10 2000-01-28 Iatron Lab Inc 新規なモノクローナル抗体及びニックβ２グリコプロテインＩの免疫学的分析方法

Also Published As

Publication number Publication date
JP2003121444A (ja) 2003-04-23
EP1443326A4 (en) 2007-08-01
US20040248200A1 (en) 2004-12-09
EP1443326A1 (en) 2004-08-04
EP1443326B1 (en) 2011-02-23
JP4070443B2 (ja) 2008-04-02
ATE499608T1 (de) 2011-03-15
WO2003034066A1 (en) 2003-04-24
US20090004750A1 (en) 2009-01-01

Similar Documents

Publication Publication Date Title
CA2465800A1 (en) Instrument
ATE347307T1 (de) Streifen zur verpackung einer mehrzahle von geräten zur flüssigkeitsentnahme und testung sowie verfahren zur herstellung und verwendung des streifens
ATE519420T1 (de) Instrument zur messung einer konzentration eines bestandteils in einer flüssigkeitsprobe
IL193426A0 (en) Methods for the diagnosis of dementia and other neurological disorders
DE60224846D1 (de) Diagnose- und/oder analysesystem am behandlungsort
WO2000072754A8 (en) Cardiopulmonary exercise testing apparatus and method
DE69430231D1 (de) Biosensor zum Messen der Alkoholkonzentration, Verfahren zur Herstellung des Biosensors, und den Biosensor benutzendes Betrunkenheitsmessgerät
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
ATE357655T1 (de) Konzentrationsmessverfahren und konzentrationsmessinstrument für spezifische komponenten
ATE412003T1 (de) Verfahren zur diagnose der alzheimer erkrankung auf der basis eines gen transkriptionsmusters
ATE98773T1 (de) Verfahren zur optischen analyse.
CA2230372A1 (en) Quantitation of p97 to diagnose and monitor alzheimer's disease
ATE297685T1 (de) Sonde und vorichtung zur messung zerebraler hämodynamik und sauerstoffsättigung
EP1260178A3 (en) Technique for diagnosing attention deficit hyperactivity disorder
ATE297018T1 (de) ßHIGH-DENSITY-LIPOPROTEINß-TESTVORRICHTUNG UND VERFAHREN
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
EP0621491A3 (en) Method for "in vivo" measurement of the concentration of xenobiotic compounds by means of magnetic resonance.
Nagel et al. Age-related changes in prefrontal white matter volume across adolescence
BR0109915A (pt) Teste de diagnóstico para doença de alzheimer
DE60239281D1 (de) Verfahren zur diagnose eines hirninfarkts
EP1197744A3 (en) Solution concentration measuring method and solution concentration measuring aparatus
Wright Correct levels of serum cholesterol: average vs normal vs optimal
Trahan Judgment of line orientation in patients with unilateral cerebrovascular lesions
Arceneaux et al. Gender Differences in WAIS–R Age-Corrected Scaled Scores
EP1063793A3 (de) Verfahren zum Messen der Signalqualität eines optischen Datensignals